Abstract:
This application provides mutant sortase molecules and methods of making and using them. In a first aspect, disclosed herein, are sortase molecules having one or a combination of mutations. In an embodiment, a sortase molecule is optimized for a parameter of enzyme performance, e.g., Ca++ dependency (or independency) or reaction rate.
Abstract:
Herein is reported a method for producing a bispecific antibody comprising the step of incubating (i) an antibody Fab fragment or a sc Fv antibody comprising within the 20 C-terminal amino acid residues the amino acid sequence LPX1TG (SEQ ID NO: 01), (ii) a one-armed antibody comprising a full length antibody heavy chain, a full length antibody light chain, and an Fc-heavy chain, whereby the full length antibody heavy chain and the full length antibody light chain are cognate antibody chains that thereof forms an antigen binding site, whereby the full length antibody heavy chain and the Fc-heavy chain are covalently linked to each other via one or more disulfide bonds forming an antibody hinge region, and whereby the Fc-heavy chain has an oligoglycine amino acid sequence at its N-terminus, and (iii) a Sortase A enzyme.
Abstract translation:本文报道了用于产生双特异性抗体的方法,其包括以下步骤:将(i)在20个C端氨基酸残基内包含氨基酸序列LPX1TG(SEQ ID NO:01)的抗体Fab片段或sc Fv抗体, (ii)包含全长抗体重链,全长抗体轻链和Fc-重链的单臂抗体,其中全长抗体重链和全长抗体轻链是其同源抗体链 形成抗原结合位点,由此全长抗体重链和Fc-重链经由形成抗体铰链区的一个或多个二硫键彼此共价连接,并且其中Fc-重链具有低聚甘氨酸氨基酸序列 在其N-末端,和(iii)分选酶A酶。
Abstract:
Herein is reported a method for producing a bispecific antibody comprising the step of incubating (i) an antibody Fab fragment or a sc Fv antibody comprising within the 20 C-terminal amino acid residues the amino acid sequence LPX1TG (SEQ ID NO: 01), (ii) a one-armed antibody comprising a full length antibody heavy chain, a full length antibody light chain, and an Fc-heavy chain, whereby the full length antibody heavy chain and the full length antibody light chain are cognate antibody chains that thereof forms an antigen binding site, whereby the full length antibody heavy chain and the Fc-heavy chain are covalently linked to each other via one or more disulfide bonds forming an antibody hinge region, and whereby the Fc-heavy chain has an oligoglycine amino acid sequence at its N-terminus, and (iii) a Sortase A enzyme.
Abstract translation:本文报道了一种制备双特异性抗体的方法,其包括以下步骤:(i)抗体Fab片段或sc Fv抗体,其包含在20个C末端氨基酸残基内的氨基酸序列LPX1TG(SEQ ID NO:01), (ii)包含全长抗体重链,全长抗体轻链和Fc重链的单臂抗体,其中全长抗体重链和全长抗体轻链是其中的同源抗体链 形成抗原结合位点,由此全长抗体重链和Fc重链通过形成抗体铰链区的一个或多个二硫键共价连接,由此Fc重链具有寡聚氨基酸序列 在其N-末端,和(iii)分选酶A酶。
Abstract:
Cell-targeted cytotoxic agents, including sortase serine protease constructs, are provided. Such compounds can be used in methods for targeted cell killing such as for treatment cell of proliferative diseases (e.g., cancer). In some aspects, recombinant sortase serine proteases, such as Granzyme B polypeptides, are provided that exhibit improved stability and cell toxicity.
Abstract:
Herein is reported a polypeptide comprising the amino acid sequence of SEQ ID NO: 38 as sole Listeria monocytogenes derived polypeptide and its use in conjugating polypeptides.
Abstract translation:本文报道了包含SEQ ID NO:38的氨基酸序列的多肽,作为单核细胞增生利斯特氏菌来源的多肽,以及其在共轭多肽中的用途。
Abstract:
본 발명은 아미노 말단에서부터 목적 단백질, LPXTG의 아미노산 서열로 이루어지는 펩타이드, 솔테이즈 A 절단 기능 도메인 및 태그의 순서로 포함하는 자가절단 융합 단백질, 이를 코딩하는 핵산, 본 발명의 핵산을 포함하는 발현벡터, 및 본 발명의 발현벡터로 형질전환된 세포에 관한 것이다. 또한, 본 발명은 상기 형질전환된 세포를 배양하여 용해 및 정제하는 단계를 포함하는 목적 단백질의 정제방법에 관한 것이다. 본 발명은 솔테이즈 A 절단 기능 도메인과 이의 인식 서열인 LPXTG의 아미노산 서열로 구성되는 펩타이드로 이루어진 자가 절단 카세트를 포함하는 자가 절단 융합 단백질에 관한 것으로, 목적 단백질의 정제 및 태그 제거 과정을 별도의 과정이 아닌 한 번의 정제 과정으로 완료할 수 있다는 점에서 매우 유용하다. 특히, 목적 단백질의 위치가 아미노 말단에 존재함으로써 융합 단백질의 컬럼 결합 능력과 자가 절단 능력을 높인 점, 태그가 제거된 목적 단백질을 고순도로 얻을 수 있는 점, 절단-버퍼를 통해 정제 및 태그 제거 과정이 한 번의 과정으로 완료되어 정제에 필요한 시간 및 노력이 획기적으로 감소되는 점, 및 한 번의 단계로 이루어지기 때문에 수득 단백질의 손실이 감소되는 점에서 고순도 및 대량의 단백질이 필요한 다양한 분야에서 널리 이용될 수 있다. 특히, 치료용항체-약물 결합체 제조에 유용하다.
Abstract:
Herein is reported a method for producing an antibody Fc-region conjugate comprising as first component an antibody Fc-region and as second component at least one binding entity that specifically binds to a target using a transpeptidase for enzymatic conjugation of the antibody Fc-region to at least one binding entity.
Abstract:
Provided are improved methods for identifying the substrate recognition specificity or activity of a protease, convertase (sortase), or kinase. In some embodiments, methods are provided for identifying the endogenous protease or convertase cleaving patterns (e.g., "cleaveOme") inside the secretory pathway of a living cell. Select embodiments involve aspects of yeast endoplasmic reticulum sequestration screening and next generation sequencing. Methods of producing polypeptides in Kex2 knockout yeast are also provided.
Abstract:
Provided are improved methods for identifying the substrate recognition specificity or activity of a protease, convertase (sortase), or kinase. In some embodiments, methods are provided for identifying the endogenous protease or convertase cleaving patterns (e.g., "cleaveOme") inside the secretory pathway of a living cell. Select embodiments involve aspects of yeast endoplasmic reticulum sequestration screening and next generation sequencing. Methods of producing polypeptides in Kex2 knockout yeast are also provided.